Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Yan Xu, Yuan Li, Jiankang Jin, Guangchun Han, Chengcao Sun, Melissa Pool Pizzi, Longfei Huo, Ailing Scott, Ying Wang, Lang Ma, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, Christopher Vellano, Liuqing Yang, Chunru Lin, Youngsoo Kim, A. Robert MacLeod, Linghua Wang, Zhenning Wang, Shumei Song, Jaffer A. Ajani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Molecular Cancer |
Online Access: | https://doi.org/10.1186/s12943-021-01351-5 |
Similar Items
-
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
by: Yan Xu, et al.
Published: (2019-10-01) -
LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
by: Yuan Li, et al.
Published: (2020-10-01) -
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
by: Shumei Song, et al.
Published: (2020-06-01) -
An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.
by: Jiankang Jin, et al.
Published: (2020-01-01) -
Drug resistance and Cancer stem cells
by: Yuan Li, et al.
Published: (2021-02-01)